Contents
Clinical Cancer Drugs, Volume 2 - Number 1
Preface
Editorial
Molecular Fundamentals and Rationale for Immunotherapy in Metastatic Melanoma Treatment
, 2(1): 4 - 15Mizue Terai and Takami Sato
DOI: 10.2174/2212697X02666150203212041
Recent Clinical Advances in the Treatment of Cutaneous Melanoma
, 2(1): 16 - 28Martin Greco, Maximiliano Mestroni, Maximo de la Vega, Gonzalo Recondo, Matias E. Valsecchi, Gonzalo Recondo and Enrique Diaz Canton
DOI: 10.2174/2212697X02666150203212708
Epidemiology, Clinical Presentation and Treatment of Uveal Melanoma
, 2(1): 29 - 37Marlana Orloff, Shingo Sato, Matias E. Valsecchi and Takami Sato
DOI: 10.2174/2212697X02666150203213809
Epidemiology, Clinical Presentation and Treatment of Mucosal Melanoma
, 2(1): 38 - 43Maximo de la Vega, Matias E. Valsecchi, Martin Greco, Gonzalo Recondo, Gonzalo Recondo and Enrique Diaz Canton
DOI: 10.2174/2212697X02666150203212942
Novel Pharmacodynamic Approach to Assess Obatoclax (GX15-070) and Bortezomib (BTZ) Synergism in Non-Hodgkin’s Lymphoma
, 2(1): 44 - 53Karen E. Thudium, Lance Wollenberg, Cory Mavis, Jenny Gu, Gerald J. Fetterly, Myron S. Czuczman and Francisco J. Hernandez-Ilizaliturri
DOI: 10.2174/2212697X02666150128003659
Glutathione for Hepatotoxicity in Patients with Liver Cirrhosis and Advanced Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy
, 2(1): 54 - 60Koichi Momiyama, Hidenari Nagai, Yu Ogino, Takanori Mukozu, Daigo Matsui, Teppei Matsui, Noritaka Wakui, Mie Shinohara, Yoshinori Igarashi and Yasukiyo Sumino
DOI: 10.2174/2212697X02666150313003755
Inhibition of Autophagy by Targeting ATG4B: Promises and Challenges of An Emerging Anti-cancer Strategy
, 2(1): 61 - 70Kelly Lien, Michelle Rocha, Elisa Tran, Van C. Hoang, Annabelle Chow and Urban Emmenegger
DOI: 10.2174/2212697X02666150331202809
Webmaster Contact: info@benthamscience.org